Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Harmonic, a Palo Alto-based artificial intelligence startup backed by Robinhood CEO Vlad Tenev, said it raised $120 million in a Series C funding round that values the company at $1.45 billion ...

Harmonic raises third funding in 14 months from insiders Focus on AI's math and reasoning capabilities Plans to explore commercial use cases in software development Nov 25 (Reuters) - Harmonic, an ...

Ribbit Capital Leads Round at $1.45B Valuation of Math-Based AI Venture; Emerson Collective Joins Existing Backers Including Sequoia & Kleiner Perkins PALO ALTO, Calif.--(BUSINESS WIRE)--Harmonic, the ...

(Reuters) -Harmonic, an artificial intelligence startup co-founded by Robinhood CEO Vlad Tenev, has raised $120 million in new funding, valuing the company at $1.45 billion, as it tackles AI ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

When Hannah Cairo was 17 years old, she disproved the Mizohata-Takeuchi conjecture, a long-standing guess in the field of harmonic analysis about how waves behave on curved surfaces. The conjecture ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...